Register to View Using Natural Language Processing to Identify Adverse Drug Events of Angiotensin Converting Enzyme Inhibitors – OMNY Health Poster

by | Jun 15, 2021

On June 9-11, 2021, this poster was on display at the virtual International Forum on Quality and Safety in Healthcare EUROPE. 

What is the Objective of this Poster?

  • Validate an end-to-end adverse drug event (ADE) detection system from the licensed software package Spark NLP for Healthcare (John Snow Labs, Inc)
  • Assess results against known ADEs of angiotensin converting enzyme inhibitors (ACE-I; a drug class for treatment of renal failure, hypertension, and heart disease)

 

Register to view the poster now!

By continuing to use the site, you agree to the use of cookies. More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below, then you are consenting to this.

Close